Ocular Therapeutix
OCUL
OCUL
75 hedge funds and large institutions have $96.4M invested in Ocular Therapeutix in 2016 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
52% less capital invested
Capital invested by funds: $201M → $96.4M (-$104M)
Holders
75
Holding in Top 10
3
Calls
$403K
Puts
$236K
Top Buyers
| 1 | +$8.13M | |
| 2 | +$2.63M | |
| 3 | +$1.75M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.29M |
| 5 |
JPMPWA
J.P. Morgan Private Wealth Advisors
San Francisco,
California
|
+$1.27M |
Top Sellers
| 1 | -$27.7M | |
| 2 | -$19.6M | |
| 3 | -$1.24M | |
| 4 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
-$1.15M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$821K |